Literature DB >> 21270098

Determination of lipoprotein lipase activity using a novel fluorescent lipase assay.

Debapriya Basu1, Jahan Manjur, Weijun Jin.   

Abstract

A novel, real-time, homogeneous fluorogenic lipoprotein lipase (LPL) assay was developed using a commercially available substrate, the EnzChek lipase substrate, which is solubilized in Zwittergent. The triglyceride analog substrate does not fluoresce, owing to apposition of fluorescent and fluorescent quenching groups at the sn-1 and sn-2 positions, respectively, fluorescence becoming unquenched upon release of the sn-1 BODIPY FA derivative following hydrolysis. Increase in fluorescence intensity at 37°C was proportional to LPL concentration. The assay was more sensitive than a similar assay using 1,2-O-dilauryl-rac-glycero-3-glutaric acid-(6-methylresorufin ester) and was validated in biological samples, including determination of LPL-specific activity in postheparin mouse plasma. The simplicity and reproducibility of the assay make it ideal for in vitro, high-throughput screening for inhibitors and activators of LPL, thus expediting discovery of drugs of potential clinical value.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270098      PMCID: PMC3284171          DOI: 10.1194/jlr.D010744

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  31 in total

1.  Positional specificity of lipoprotein lipase.

Authors:  N Morley; A Kuksis
Journal:  J Biol Chem       Date:  1972-10-25       Impact factor: 5.157

Review 2.  Triglyceride lipases and atherosclerosis.

Authors:  Gunilla Olivecrona; Thomas Olivecrona
Journal:  Curr Opin Lipidol       Date:  2010-10       Impact factor: 4.776

3.  Characterization of the lipolytic activity of endothelial lipase.

Authors:  Mary G McCoy; Gwo-Shing Sun; Dawn Marchadier; Cyrille Maugeais; Jane M Glick; Daniel J Rader
Journal:  J Lipid Res       Date:  2002-06       Impact factor: 5.922

Review 4.  Lipoprotein lipase: physiology, biochemistry, and molecular biology.

Authors:  I J Goldberg; M Merkel
Journal:  Front Biosci       Date:  2001-03-01

Review 5.  Lipases and HDL metabolism.

Authors:  Weijun Jin; Dawn Marchadier; Daniel J Rader
Journal:  Trends Endocrinol Metab       Date:  2002 May-Jun       Impact factor: 12.015

6.  A real-time fluorogenic phospholipase A(2) assay for biochemical and cellular activity measurements.

Authors:  Li Feng; Kelly Manabe; Joseph C Shope; Stanton Widmer; Daryll B DeWald; Glenn D Prestwich
Journal:  Chem Biol       Date:  2002-07

7.  ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase.

Authors:  Tetsuya Shimizugawa; Mitsuru Ono; Mitsuru Shimamura; Kenichi Yoshida; Yosuke Ando; Ryuta Koishi; Kenjiro Ueda; Toshimori Inaba; Hiroyuki Minekura; Takafumi Kohama; Hidehiko Furukawa
Journal:  J Biol Chem       Date:  2002-07-03       Impact factor: 5.157

8.  ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.

Authors:  Frank G Schaap; Patrick C N Rensen; Peter J Voshol; Carlos Vrins; Hendrik N van der Vliet; Robert A F M Chamuleau; Louis M Havekes; Albert K Groen; Ko Willems van Dijk
Journal:  J Biol Chem       Date:  2004-04-16       Impact factor: 5.157

9.  Mechanism of salt-mediated inhibition of lipoprotein lipase.

Authors:  C J Fielding; P E Fielding
Journal:  J Lipid Res       Date:  1976-05       Impact factor: 5.922

10.  Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy.

Authors:  Hiroaki Yagyu; Guangping Chen; Masayoshi Yokoyama; Kumiko Hirata; Ayanna Augustus; Yuko Kako; Toru Seo; Yunying Hu; E Peer Lutz; Martin Merkel; André Bensadoun; Shunichi Homma; Ira J Goldberg
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

View more
  19 in total

1.  A novel NanoBiT-based assay monitors the interaction between lipoprotein lipase and GPIHBP1 in real time.

Authors:  Shwetha K Shetty; Rosemary L Walzem; Brandon S J Davies
Journal:  J Lipid Res       Date:  2020-02-06       Impact factor: 5.922

2.  Lipoprotein lipase activity and interactions studied in human plasma by isothermal titration calorimetry.

Authors:  Mart Reimund; Oleg Kovrov; Gunilla Olivecrona; Aivar Lookene
Journal:  J Lipid Res       Date:  2016-11-14       Impact factor: 5.922

3.  Simplified assays of lipolysis enzymes for drug discovery and specificity assessment of known inhibitors.

Authors:  Jose Iglesias; Julien Lamontagne; Heidi Erb; Sari Gezzar; Shangang Zhao; Erik Joly; Vouy Linh Truong; Kathryn Skorey; Sheldon Crane; S R Murthy Madiraju; Marc Prentki
Journal:  J Lipid Res       Date:  2015-09-30       Impact factor: 5.922

4.  Endocytosis of very low-density lipoproteins: an unexpected mechanism for lipid acquisition by breast cancer cells.

Authors:  Leslie E Lupien; Katarzyna Bloch; Jonas Dehairs; Nicole A Traphagen; William W Feng; Wilson L Davis; Thea Dennis; Johannes V Swinnen; Wendy A Wells; Nicole C Smits; Nancy B Kuemmerle; Todd W Miller; William B Kinlaw
Journal:  J Lipid Res       Date:  2019-12-05       Impact factor: 5.922

5.  Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1.

Authors:  Xun Chi; Shwetha K Shetty; Hannah W Shows; Alexander J Hjelmaas; Emily K Malcolm; Brandon S J Davies
Journal:  J Biol Chem       Date:  2015-03-25       Impact factor: 5.157

6.  ANGPTL8 Blockade With a Monoclonal Antibody Promotes Triglyceride Clearance, Energy Expenditure, and Weight Loss in Mice.

Authors:  Viktoria Gusarova; Serena Banfi; Corey A Alexa-Braun; Lisa M Shihanian; Ivory J Mintah; Joseph S Lee; Yurong Xin; Qi Su; Vishal Kamat; Jonathan C Cohen; Helen H Hobbs; Brian Zambrowicz; George D Yancopoulos; Andrew J Murphy; Jesper Gromada
Journal:  Endocrinology       Date:  2017-05-01       Impact factor: 4.736

7.  ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance.

Authors:  Jorge F Haller; Ivory J Mintah; Lisa M Shihanian; Panayiotis Stevis; David Buckler; Corey A Alexa-Braun; Sandra Kleiner; Serena Banfi; Jonathan C Cohen; Helen H Hobbs; George D Yancopoulos; Andrew J Murphy; Viktoria Gusarova; Jesper Gromada
Journal:  J Lipid Res       Date:  2017-04-15       Impact factor: 5.922

8.  CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins.

Authors:  Masami Shimizu-Albergine; Debapriya Basu; Jenny E Kanter; Farah Kramer; Vishal Kothari; Shelley Barnhart; Carissa Thornock; Adam E Mullick; Noemie Clouet-Foraison; Tomas Vaisar; Jay W Heinecke; Robert A Hegele; Ira J Goldberg; Karin E Bornfeldt
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 14.808

9.  Measurement of the phospholipase activity of endothelial lipase in mouse plasma.

Authors:  Debapriya Basu; Xia Lei; Joby Josekutty; M Mahmood Hussain; Weijun Jin
Journal:  J Lipid Res       Date:  2012-10-26       Impact factor: 5.922

10.  Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects.

Authors:  Mathilde Di Filippo; Christophe Marçais; Sybil Charrière; Oriane Marmontel; Martine Broyer; Mireille Delay; Micheline Merlin; Axel Nollace; René Valéro; Michel Lagarde; Valérie Pruneta-Deloche; Philippe Moulin; Agnès Sassolas
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.